Dec 3, 2024, 18:58
Katy Beckermann: The role of belzutifan in treating rare mutation VHL congenital-related polycythemia
Katy Beckermann, Assistant Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center, shared on X:
“Excited to share this case report led by the brilliant Paulo Amaral! It highlights the role of belzutifan in treating rare mutation VHL congenital-related polycythemia, showcasing its efficacy and safety.”
Von Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan
Authors: Paulo Siqueira do Amaral, Sanjay R. Mohan, Kathryn E. Beckermann
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 11, 2025, 10:28
Feb 11, 2025, 10:28
Feb 11, 2025, 10:24
Feb 11, 2025, 10:15
Feb 11, 2025, 09:58
Feb 11, 2025, 09:48